Department profile
Hogan Lovells Cadwalader

Life Sciences

Global Guide 2026 : Asia-Pacific Region

Share profile

Hogan Lovells Cadwalader

About

Provided by Hogan Lovells Cadwalader

Navigating complexities in the life sciences and health care industries is no easy task. Successfully competing in the space requires increasingly creative strategies and integrated solutions that protect and support your business day in and day out.

Regardless of the sector of the health care industry you operate or the maturity of your products, we understand how to bridge the gap between the challenges you face and the outcome you want. From budding startups to multinational enterprises, we've been there before and know how to position you for success. 

With more than 500 life sciences and health care lawyers across the globe, we work closely with you and each other to tackle tough issues and difficult-to enter markets - no matter where you are today or want to be tomorrow. And because we know what makes your industry tick, we have a deep understanding of the issues you face - helping you stay ahead of the curve and on top of your opportunities. 

Whatever your challenge, wherever the issue, Hogan Lovells Cadwalader has you covered.

Industries (5)

  • Pharmaceutical and Biotechnology
  • Medical Devices
  • Healthcare Services
  • Hospitals and Healthcare Providers
  • Digital Health

Chambers Review

Provided by Chambers

Life Sciences - Asia-Pacific Region

Band 1

What the Team is Known For

Hogan Lovells Cadwalader has a respected Asia-wide practice with an established presence in China and Japan. The team is capable of advising companies across the spectrum of life sciences issues, with expertise in the fields of commercial agreements, product liability, disputes, investigations and compliance. Hogan Lovells Cadwalader is known for its work on IP protection and enforcement, cross-border transactions and FDI matters and handles work for a strong roster of leading global pharmaceutical, medical device and biotech companies. The firm also boasts capable corporate M&A expertise to bolster its life sciences offering.

Notable practitioners

Tokyo-based Frederick Ch'en is a main contact for the firm's Japan life sciences practice and Zhou Lu and Calvin Ding are key contacts in China.

View ranking table

Work Highlights

Provided by Chambers

  • Hogan Lovells International advised Shimadzu Corporation on its investments in Sepragen Corporation and U-Medico.

Strengths

Provided by Chambers

  • They advise not only from a legal point of view, but also from a pharmaceutical and biotech perspective. They are strong in cases that are particularly complex and require scientific understanding.

    Life Sciences respondentGlobal

Members

Provided by Hogan Lovells Cadwalader

  • Frederick Ch'en

  • Adrian Emch

  • Andrew McGinty

  • Roy Zou

  • Biswajit Chatterjee

  • Lu Zhou

  • Mandi Jacobson

  • Calvin Ding

  • Tony Mou

  • Sammy Li

  • Andrew Cobden

  • Jessie Xie

Hogan Lovells Cadwalader has rankings in the following guides

What success is built on

Chambers is the leading data and intelligence partner for the legal sector.

Explore thought leadership